ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oxytocin Injection Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-35Y6730
Home | Market Reports | Health| Reproductive Health
Global Oxytocin Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Oxytocin Injection Market Research Report 2025

Code: QYRE-Auto-35Y6730
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
JHP Pharmaceuticals
Grindex
Pfizer Inc
Novartis
GSK
Bimeda
Bayer
Agrilab
Kepro B.V.
Hybio Pharmaceutical
Shanghai Hefeng
Renjian Pharmaceutical

Oxytocin Injection Market

The global market for Oxytocin Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oxytocin injection is a synthetic form of oxytocin, a hormone that is naturally produced by the pituitary gland in the brain. Oxytocin is responsible for stimulating uterine contractions during labor and milk ejection during breastfeeding . Oxytocin injection is used to induce or augment labor, to control postpartum bleeding, or to terminate pregnancy . Oxytocin injection is administered intravenously or intramuscularly by a health care professional . According to the U.S. Food and Drug Administration, oxytocin injection is defined as “a sterile, clear, colorless aqueous solution of synthetic oxytocin, for intravenous infusion or intramuscular injection.
The industry trend of oxytocin injection is influenced by several factors, such as:
The increasing demand for oxytocin injection in various regions of the world, especially in low- and middle-income countries where maternal mortality and morbidity are high due to complications of childbirth .
The growing awareness of the benefits and risks of oxytocin injection among consumers and health professionals, which encourages the appropriate use and regulation of oxytocin injection for different indications .
The advancement of technology and innovation that enable the improvement of oxytocin injection quality, safety, efficacy, and accessibility .
Some examples of the industry trend of oxytocin injection are:
The emergence of new applications of oxytocin injection in different fields, such as psychiatry, neurology, and oncology .
The development of new formulations and delivery systems of oxytocin injection that enhance its stability, bioavailability, and convenience .
The introduction of new standards and guidelines that ensure the quality and safety of oxytocin injection in the global market .

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oxytocin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxytocin Injection.
The Oxytocin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oxytocin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxytocin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oxytocin Injection Market Report

Report Metric Details
Report Name Oxytocin Injection Market
Segment by Type
  • Oxytocin
  • Carbetocin
Segment by Application
  • Animal Use
  • Human Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company JHP Pharmaceuticals, Grindex, Pfizer, Novartis, GSK, Bimeda, Bayer, Agrilab, Kepro B.V., Hybio Pharmaceutical, Shanghai Hefeng, Renjian Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oxytocin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oxytocin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oxytocin Injection Market report?

Ans: The main players in the Oxytocin Injection Market are JHP Pharmaceuticals, Grindex, Pfizer, Novartis, GSK, Bimeda, Bayer, Agrilab, Kepro B.V., Hybio Pharmaceutical, Shanghai Hefeng, Renjian Pharmaceutical

What are the Application segmentation covered in the Oxytocin Injection Market report?

Ans: The Applications covered in the Oxytocin Injection Market report are Animal Use, Human Use

What are the Type segmentation covered in the Oxytocin Injection Market report?

Ans: The Types covered in the Oxytocin Injection Market report are Oxytocin, Carbetocin

1 Oxytocin Injection Market Overview
1.1 Product Definition
1.2 Oxytocin Injection by Type
1.2.1 Global Oxytocin Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oxytocin
1.2.3 Carbetocin
1.3 Oxytocin Injection by Application
1.3.1 Global Oxytocin Injection Market Value by Application (2024 VS 2031)
1.3.2 Animal Use
1.3.3 Human Use
1.4 Global Oxytocin Injection Market Size Estimates and Forecasts
1.4.1 Global Oxytocin Injection Revenue 2020-2031
1.4.2 Global Oxytocin Injection Sales 2020-2031
1.4.3 Global Oxytocin Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oxytocin Injection Market Competition by Manufacturers
2.1 Global Oxytocin Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oxytocin Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oxytocin Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oxytocin Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oxytocin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxytocin Injection, Product Type & Application
2.7 Global Key Manufacturers of Oxytocin Injection, Date of Enter into This Industry
2.8 Global Oxytocin Injection Market Competitive Situation and Trends
2.8.1 Global Oxytocin Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oxytocin Injection Players Market Share by Revenue
2.8.3 Global Oxytocin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oxytocin Injection Market Scenario by Region
3.1 Global Oxytocin Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oxytocin Injection Sales by Region: 2020-2031
3.2.1 Global Oxytocin Injection Sales by Region: 2020-2025
3.2.2 Global Oxytocin Injection Sales by Region: 2026-2031
3.3 Global Oxytocin Injection Revenue by Region: 2020-2031
3.3.1 Global Oxytocin Injection Revenue by Region: 2020-2025
3.3.2 Global Oxytocin Injection Revenue by Region: 2026-2031
3.4 North America Oxytocin Injection Market Facts & Figures by Country
3.4.1 North America Oxytocin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oxytocin Injection Sales by Country (2020-2031)
3.4.3 North America Oxytocin Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oxytocin Injection Market Facts & Figures by Country
3.5.1 Europe Oxytocin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oxytocin Injection Sales by Country (2020-2031)
3.5.3 Europe Oxytocin Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxytocin Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Oxytocin Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oxytocin Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Oxytocin Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oxytocin Injection Market Facts & Figures by Country
3.7.1 Latin America Oxytocin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oxytocin Injection Sales by Country (2020-2031)
3.7.3 Latin America Oxytocin Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oxytocin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxytocin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oxytocin Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oxytocin Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oxytocin Injection Sales by Type (2020-2031)
4.1.1 Global Oxytocin Injection Sales by Type (2020-2025)
4.1.2 Global Oxytocin Injection Sales by Type (2026-2031)
4.1.3 Global Oxytocin Injection Sales Market Share by Type (2020-2031)
4.2 Global Oxytocin Injection Revenue by Type (2020-2031)
4.2.1 Global Oxytocin Injection Revenue by Type (2020-2025)
4.2.2 Global Oxytocin Injection Revenue by Type (2026-2031)
4.2.3 Global Oxytocin Injection Revenue Market Share by Type (2020-2031)
4.3 Global Oxytocin Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oxytocin Injection Sales by Application (2020-2031)
5.1.1 Global Oxytocin Injection Sales by Application (2020-2025)
5.1.2 Global Oxytocin Injection Sales by Application (2026-2031)
5.1.3 Global Oxytocin Injection Sales Market Share by Application (2020-2031)
5.2 Global Oxytocin Injection Revenue by Application (2020-2031)
5.2.1 Global Oxytocin Injection Revenue by Application (2020-2025)
5.2.2 Global Oxytocin Injection Revenue by Application (2026-2031)
5.2.3 Global Oxytocin Injection Revenue Market Share by Application (2020-2031)
5.3 Global Oxytocin Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 JHP Pharmaceuticals
6.1.1 JHP Pharmaceuticals Company Information
6.1.2 JHP Pharmaceuticals Description and Business Overview
6.1.3 JHP Pharmaceuticals Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 JHP Pharmaceuticals Oxytocin Injection Product Portfolio
6.1.5 JHP Pharmaceuticals Recent Developments/Updates
6.2 Grindex
6.2.1 Grindex Company Information
6.2.2 Grindex Description and Business Overview
6.2.3 Grindex Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grindex Oxytocin Injection Product Portfolio
6.2.5 Grindex Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Oxytocin Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Oxytocin Injection Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 GSK
6.5.1 GSK Company Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GSK Oxytocin Injection Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Bimeda
6.6.1 Bimeda Company Information
6.6.2 Bimeda Description and Business Overview
6.6.3 Bimeda Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bimeda Oxytocin Injection Product Portfolio
6.6.5 Bimeda Recent Developments/Updates
6.7 Bayer
6.7.1 Bayer Company Information
6.7.2 Bayer Description and Business Overview
6.7.3 Bayer Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer Oxytocin Injection Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Agrilab
6.8.1 Agrilab Company Information
6.8.2 Agrilab Description and Business Overview
6.8.3 Agrilab Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Agrilab Oxytocin Injection Product Portfolio
6.8.5 Agrilab Recent Developments/Updates
6.9 Kepro B.V.
6.9.1 Kepro B.V. Company Information
6.9.2 Kepro B.V. Description and Business Overview
6.9.3 Kepro B.V. Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Kepro B.V. Oxytocin Injection Product Portfolio
6.9.5 Kepro B.V. Recent Developments/Updates
6.10 Hybio Pharmaceutical
6.10.1 Hybio Pharmaceutical Company Information
6.10.2 Hybio Pharmaceutical Description and Business Overview
6.10.3 Hybio Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hybio Pharmaceutical Oxytocin Injection Product Portfolio
6.10.5 Hybio Pharmaceutical Recent Developments/Updates
6.11 Shanghai Hefeng
6.11.1 Shanghai Hefeng Company Information
6.11.2 Shanghai Hefeng Description and Business Overview
6.11.3 Shanghai Hefeng Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Hefeng Oxytocin Injection Product Portfolio
6.11.5 Shanghai Hefeng Recent Developments/Updates
6.12 Renjian Pharmaceutical
6.12.1 Renjian Pharmaceutical Company Information
6.12.2 Renjian Pharmaceutical Description and Business Overview
6.12.3 Renjian Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Renjian Pharmaceutical Oxytocin Injection Product Portfolio
6.12.5 Renjian Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxytocin Injection Industry Chain Analysis
7.2 Oxytocin Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxytocin Injection Production Mode & Process Analysis
7.4 Oxytocin Injection Sales and Marketing
7.4.1 Oxytocin Injection Sales Channels
7.4.2 Oxytocin Injection Distributors
7.5 Oxytocin Injection Customer Analysis
8 Oxytocin Injection Market Dynamics
8.1 Oxytocin Injection Industry Trends
8.2 Oxytocin Injection Market Drivers
8.3 Oxytocin Injection Market Challenges
8.4 Oxytocin Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
JHP Pharmaceuticals
Grindex
Pfizer Inc
Novartis
GSK
Bimeda
Bayer
Agrilab
Kepro B.V.
Hybio Pharmaceutical
Shanghai Hefeng
Renjian Pharmaceutical
List of Tables
 Table 1. Global Oxytocin Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oxytocin Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oxytocin Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oxytocin Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oxytocin Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oxytocin Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oxytocin Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oxytocin Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oxytocin Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oxytocin Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oxytocin Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Oxytocin Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oxytocin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxytocin Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oxytocin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oxytocin Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oxytocin Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Oxytocin Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oxytocin Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Oxytocin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oxytocin Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Oxytocin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oxytocin Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Oxytocin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oxytocin Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oxytocin Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oxytocin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oxytocin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oxytocin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oxytocin Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oxytocin Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oxytocin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oxytocin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oxytocin Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oxytocin Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oxytocin Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oxytocin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oxytocin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oxytocin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oxytocin Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oxytocin Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oxytocin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oxytocin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oxytocin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oxytocin Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oxytocin Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oxytocin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oxytocin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oxytocin Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Oxytocin Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Oxytocin Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Oxytocin Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Oxytocin Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oxytocin Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oxytocin Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Oxytocin Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Oxytocin Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oxytocin Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oxytocin Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Oxytocin Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Oxytocin Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Oxytocin Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Oxytocin Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oxytocin Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oxytocin Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Oxytocin Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Oxytocin Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oxytocin Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. JHP Pharmaceuticals Company Information
 Table 71. JHP Pharmaceuticals Description and Business Overview
 Table 72. JHP Pharmaceuticals Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. JHP Pharmaceuticals Oxytocin Injection Product
 Table 74. JHP Pharmaceuticals Recent Developments/Updates
 Table 75. Grindex Company Information
 Table 76. Grindex Description and Business Overview
 Table 77. Grindex Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Grindex Oxytocin Injection Product
 Table 79. Grindex Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Oxytocin Injection Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Oxytocin Injection Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. GSK Company Information
 Table 91. GSK Description and Business Overview
 Table 92. GSK Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GSK Oxytocin Injection Product
 Table 94. GSK Recent Developments/Updates
 Table 95. Bimeda Company Information
 Table 96. Bimeda Description and Business Overview
 Table 97. Bimeda Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bimeda Oxytocin Injection Product
 Table 99. Bimeda Recent Developments/Updates
 Table 100. Bayer Company Information
 Table 101. Bayer Description and Business Overview
 Table 102. Bayer Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bayer Oxytocin Injection Product
 Table 104. Bayer Recent Developments/Updates
 Table 105. Agrilab Company Information
 Table 106. Agrilab Description and Business Overview
 Table 107. Agrilab Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Agrilab Oxytocin Injection Product
 Table 109. Agrilab Recent Developments/Updates
 Table 110. Kepro B.V. Company Information
 Table 111. Kepro B.V. Description and Business Overview
 Table 112. Kepro B.V. Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Kepro B.V. Oxytocin Injection Product
 Table 114. Kepro B.V. Recent Developments/Updates
 Table 115. Hybio Pharmaceutical Company Information
 Table 116. Hybio Pharmaceutical Description and Business Overview
 Table 117. Hybio Pharmaceutical Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Hybio Pharmaceutical Oxytocin Injection Product
 Table 119. Hybio Pharmaceutical Recent Developments/Updates
 Table 120. Shanghai Hefeng Company Information
 Table 121. Shanghai Hefeng Description and Business Overview
 Table 122. Shanghai Hefeng Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shanghai Hefeng Oxytocin Injection Product
 Table 124. Shanghai Hefeng Recent Developments/Updates
 Table 125. Renjian Pharmaceutical Company Information
 Table 126. Renjian Pharmaceutical Description and Business Overview
 Table 127. Renjian Pharmaceutical Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Renjian Pharmaceutical Oxytocin Injection Product
 Table 129. Renjian Pharmaceutical Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Oxytocin Injection Distributors List
 Table 133. Oxytocin Injection Customers List
 Table 134. Oxytocin Injection Market Trends
 Table 135. Oxytocin Injection Market Drivers
 Table 136. Oxytocin Injection Market Challenges
 Table 137. Oxytocin Injection Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oxytocin Injection
 Figure 2. Global Oxytocin Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oxytocin Injection Market Share by Type: 2024 & 2031
 Figure 4. Oxytocin Product Picture
 Figure 5. Carbetocin Product Picture
 Figure 6. Global Oxytocin Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Oxytocin Injection Market Share by Application: 2024 & 2031
 Figure 8. Animal Use
 Figure 9. Human Use
 Figure 10. Global Oxytocin Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Oxytocin Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Oxytocin Injection Sales (2020-2031) & (K Units)
 Figure 13. Global Oxytocin Injection Average Price (US$/Unit) & (2020-2031)
 Figure 14. Oxytocin Injection Report Years Considered
 Figure 15. Oxytocin Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Oxytocin Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Oxytocin Injection Players: Market Share by Revenue in Oxytocin Injection in 2024
 Figure 18. Oxytocin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Oxytocin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Oxytocin Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Oxytocin Injection Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Oxytocin Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Oxytocin Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Oxytocin Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Oxytocin Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Oxytocin Injection Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Oxytocin Injection Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Oxytocin Injection Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Oxytocin Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Oxytocin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Oxytocin Injection by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Oxytocin Injection by Type (2020-2031)
 Figure 55. Global Oxytocin Injection Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Oxytocin Injection by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Oxytocin Injection by Application (2020-2031)
 Figure 58. Global Oxytocin Injection Price (US$/Unit) by Application (2020-2031)
 Figure 59. Oxytocin Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Posterior Pituitary for Injection Market Research Report 2024
Global Carbetocin for Injection Market Research Report 2024
Global Oxytocin Market Insights Forecast to 2030
Oxytocic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oxytocic Pharmaceuticals Market Research Report 2024
Global Carbetocin Injection Market Research Report 2024
Global Pharmaceutical Grade Carbetocin Market Research Report 2025
Global Carbetocin API for Human Use Market Research Report 2025
Global Carbetocin API Market Research Report 2025
Global Oxytocin Receptor Inhibitors Market Research Report 2024
Global Oxytocin Supplement Market Research Report 2024
Global Atosiban Acetate for Injection Market Research Report 2024
Global Oxytocic Pharmaceutical Market Research Report 2025
Global Atosiban Market Insights Forecast to 2030
Global Heat Stable Carbetocin Market Research Report 2024
Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Global Recombinant FSH Injections Market Research Report 2024
Global Somatostatin for Injection Market Research Report 2024
Global Injectable Fertility Medications Market Research Report 2024
Global Pituitary Hormone Infusion Pump Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions